These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


269 related items for PubMed ID: 5139202

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The effectiveness of combined phenothiazine and butyrophenone treatment in chronic schizophrenic patients.
    Lehmann HE, Ban TA, Lee H.
    Curr Ther Res Clin Exp; 1967 Jan; 9(1):36-7. PubMed ID: 4963021
    [No Abstract] [Full Text] [Related]

  • 23. Optimum use of antipsychotic drugs.
    Hollister LE.
    Curr Psychiatr Ther; 1972 Jan; 12():81-8. PubMed ID: 5032916
    [No Abstract] [Full Text] [Related]

  • 24. Pilot study on the use of AL-1021 in the treatment of chronic schizophrenia.
    Angus JW, Go SH, Simpson GM.
    Curr Ther Res Clin Exp; 1969 Dec; 11(12):779-83. PubMed ID: 4984043
    [No Abstract] [Full Text] [Related]

  • 25. [Therapeutic experiences with oxazepam--a derivative of the benzodiazepine series--in child and adolescent psychiatry].
    Nievoll A.
    Wien Klin Wochenschr; 1971 Apr 09; 83(14):251-4. PubMed ID: 5559790
    [No Abstract] [Full Text] [Related]

  • 26. [Flupenthixol in the treatment of chronic schizophrenia].
    Arnone A, Parodi A, Masini A, Ambrosini G.
    Riv Sper Freniatr Med Leg Alien Ment; 1970 Apr 30; 94(2):351-74. PubMed ID: 5484960
    [No Abstract] [Full Text] [Related]

  • 27. [No. 233. Elementary prescriptions for therapy of states of excitement].
    Argenta G.
    Clin Ter; 1971 Jul 30; 57(6):573-6. PubMed ID: 5136491
    [No Abstract] [Full Text] [Related]

  • 28. Flupenthixol depot in the maintenance treatment of psychoses.
    Svestka J, Náhunek K.
    Act Nerv Super (Praha); 1972 Jul 30; 14(2):94-5. PubMed ID: 5040180
    [No Abstract] [Full Text] [Related]

  • 29. Effect of trifluperidol (R 2498) on the urinary elimination of bufotenin in schizophrenia.
    Acebal EM, Spatz H.
    Int J Neuropsychiatry; 1967 Dec 30; 3(6):472-6. PubMed ID: 5583441
    [No Abstract] [Full Text] [Related]

  • 30. [The Wartegg-Sign-Test in schizophrenics].
    Knorr W, Rennert H.
    Fortschr Neurol Psychiatr Grenzgeb; 1966 May 30; 34(5):276-96. PubMed ID: 5339269
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Thiothixene in the treatment of paranoid psychoses.
    Medvecký J, Safko S, Medvecká E.
    Act Nerv Super (Praha); 1972 May 30; 14(2):92-3. PubMed ID: 5040179
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Clinical evaluation of thiothixene in acute newly admitted schizophrenic patients.
    Ngui PW, Teo SH.
    Singapore Med J; 1971 Aug 30; 12(4):227-32. PubMed ID: 5129906
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 14.